Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 10, 2010, Pages 1143-1150

  Morgan, Maria A ^a   Cragan, Janet D ^b   Goldenberg, Robert L ^c   Rasmussen, Sonja A ^b   Schulkin, Jay ^a  

^a INTER AMERICAN DEVELOPMENT BANK   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Medication; over the counter; pregnancy; pregnancy exposure registry; prescription; questionnaire; safety; teratogenic

Indexed keywords

ACETYLSALICYLIC ACID; VALPROIC ACID;

ACCESS TO INFORMATION; ADULT; ARTICLE; CLINICAL PRACTICE; COUNSELING; DRUG EXPOSURE; DRUG USE; FEMALE; GYNECOLOGY; HUMAN; KNOWLEDGE; MALE; OBSTETRIC CARE; OBSTETRICS; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; TERATOGENICITY;

ADULT; CLINICAL COMPETENCE; DATA COLLECTION; DRUG TOXICITY; FEMALE; GYNECOLOGY; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; OBSTETRICS; PREGNANCY; TERATOGENS;

EID: 77956565131     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767051003653252     Document Type: Article

References (28)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-96.
2. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-29.
3. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002; 100:465-473.
4. Mitchell AA, editor. Special considerations in studies of druginduced birth defects. Hoboken, NJ: John Wiley & Sons; 2000.
5. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398-407.
6. US Food and Drug Administration Center for Drug Evaluation and Research. Guidance for Industry. Establishing Pregnancy Exposure Registries. Internet. 2002. Electronic Citation. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM071639. pdf. Last accessed June 2009.
7. Schwarz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med 2005;118:1240-1249.
8. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771-777.
9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: a reference guide to fetal and neonatal risk. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
10. Moretti ME, Maxson A, Hanna F, Koren G. Evaluating the safety of St. Johns Wort in human pregnancy. Reprod Toxicol 2009;28:96-99.
11. Physicians Desk Reference 2009. Thomson Reuters. 63rd ed., Montvale, NJ, USA (November 30, 2008).
12. Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol 2008; 51:106-118.
13. Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, Sorokin Y. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol 2005;22:321-324.
14. Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188:1039-1045.
15. Lapi F, Vannacci A, Moschini M, Cipollini F, Morsuillo M, Gallo E, Banchelli G, Cecchi E, Pirro MD, Giovannini MG, et al. Use, attitudes and knowledge of complementary and alternative drugs (CADs) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med, May 7 eCAM 2008. DOI:10.1093/ecam/nen031.
16. Li DK, Liu L, Odouli R. Exposure to non-steroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368-372.
17. Friedman JM. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 2000;62: 134-137.
18. Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol 2005;105 (5 Pt 1):1119-1122.
19. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61: 2163-2175. (Pubitemid 34074799)
20. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-344.
21. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs-is the current system adequate to inform of risks? Am J Obstet Gynecol 2002;187: 333-339.
22. Public Affairs Committee of the Teratology Society. Teratology Public Affairs Committee position paper: pregnancy labeling for prescription drugs: ten years later. Birth Defects Res (Part A) 2007;79:627-630.
23. Ahn HK, Choi JS, Han JY, Kim MH, Chung JH, Ryu HM, Kim MY, Yang JH, Koong MK, Nava-Ocampo AA, et al. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period. Hum Exp Toxicol 2008; 27:307-313.
24. Jellesen R, Strandberg-Larsen K, Jørgensen T, Olsen J, Thulstrup AM, Andersen AM. Maternal use of oral contraceptives and risk of fetal death. Paediatr Perinat Epidemiol 2008;22:334-340.
25. Feibus KB. FDAs proposed rule for pregnancy and lactation labeling: improving maternal child health through wellinformed medicine use. J Med Toxicol 2008;4:284-288.
26. FDA web page listing registries to the references Internet. 2009. Electronic Citation. http://www.fda.gov/Science Research/SpecialTopics/ WomensHealthResearch/ucm134848. htm). Last accessed February 2010.
27. Morgan MA, Crall J, Goldenberg RL, Schulkin J. Oral health during pregnancy. J Matern Fetal Neonatal Med 2009;22: 733-739.
28. Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009;200:459 e1-459 e9.